Most tertiary lymphoid structures did not have any FEN1 expression, but when present, it is an independent predictor of decreased DFS and worse recurrence-free survival (RFS) of PCa with higher efficiency than that of TN classification (Isohookana et al., 2018). The gene discussed is FEN1; the disease is posterior cortical atrophy.